Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma

NCT07547592 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site

Interventions

DRUG: Bev + Gem + Doc
DRUG: Gem + Doc

Sponsor

Yonsei University